1. Home
  2. THTX vs XBIT Comparison

THTX vs XBIT Comparison

Compare THTX & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THTX
  • XBIT
  • Stock Information
  • Founded
  • THTX 1993
  • XBIT 2005
  • Country
  • THTX Canada
  • XBIT United States
  • Employees
  • THTX N/A
  • XBIT N/A
  • Industry
  • THTX Biotechnology: Pharmaceutical Preparations
  • XBIT Pharmaceuticals and Biotechnology
  • Sector
  • THTX Health Care
  • XBIT Health Care
  • Exchange
  • THTX Nasdaq
  • XBIT Nasdaq
  • Market Cap
  • THTX 118.2M
  • XBIT 105.2M
  • IPO Year
  • THTX N/A
  • XBIT 2015
  • Fundamental
  • Price
  • THTX $2.62
  • XBIT $2.77
  • Analyst Decision
  • THTX Hold
  • XBIT
  • Analyst Count
  • THTX 1
  • XBIT 0
  • Target Price
  • THTX N/A
  • XBIT N/A
  • AVG Volume (30 Days)
  • THTX 6.2M
  • XBIT 60.8K
  • Earning Date
  • THTX 04-09-2025
  • XBIT 05-20-2025
  • Dividend Yield
  • THTX N/A
  • XBIT N/A
  • EPS Growth
  • THTX N/A
  • XBIT N/A
  • EPS
  • THTX N/A
  • XBIT N/A
  • Revenue
  • THTX $88,666,000.00
  • XBIT N/A
  • Revenue This Year
  • THTX N/A
  • XBIT N/A
  • Revenue Next Year
  • THTX $15.13
  • XBIT N/A
  • P/E Ratio
  • THTX N/A
  • XBIT N/A
  • Revenue Growth
  • THTX 13.52
  • XBIT N/A
  • 52 Week Low
  • THTX $1.08
  • XBIT $2.65
  • 52 Week High
  • THTX $3.13
  • XBIT $9.45
  • Technical
  • Relative Strength Index (RSI)
  • THTX 57.56
  • XBIT 41.56
  • Support Level
  • THTX $2.64
  • XBIT $2.71
  • Resistance Level
  • THTX $2.82
  • XBIT $3.08
  • Average True Range (ATR)
  • THTX 0.17
  • XBIT 0.22
  • MACD
  • THTX -0.04
  • XBIT -0.01
  • Stochastic Oscillator
  • THTX 20.45
  • XBIT 17.91

About THTX Theratechnologies Inc.

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.

About XBIT XBiotech Inc.

XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.

Share on Social Networks: